Organic Light-Emitting Diodes for Optogenetic Control of Neurons

Project Information

NeurOLED

Grant agreement ID: 703387

DOI

10.3030/703387

Project closed

EC signature date 16 February 2016

Start date 1 March 2016

End date 18 July 2018

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 195 454,80

EU contribution

€ 195 454,80

Coordinated by

THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
United Kingdom

Periodic Reporting for period 1 - NeurOLED (Organic Light-Emitting Diodes for Optogenetic Control of Neurons)

Reporting period: 2016-03-01 to 2018-02-28

Summary of the context and overall objectives of the project

Optogenetics is an emerging technique in neuroscience that allows controlling cells with light. One of the main limitations so far is the low spatial resolution of the available light sources which prevents specific optical targeting of individual cells or groups of cells. Furthermore, the rigidity of the traditional light sources is hardly compatible with soft biological tissue.
The NeurOLED project aimed at developing a new light source for optogenetics based on organic light-emitting diodes (OLEDs). OLEDs are based on extremely thin layers of organic compounds, can be structured to high-density arrays and may be fabricated on flexible plastic foils. Thus, they can overcome limitations of existing light sources and enable high-resolution optogenetic stimulation of cells over both small and large areas.
Due to the high brightness requirements for optogenetics, the harsh aqueous environment, and the need for small pixel arrays – all of which are not standard for OLEDs –, a large part of the project looked at adapting OLED technology for this new application. To demonstrate the usability of OLEDs in optogenetics, neurons were stimulated both in vitro and in vivo.
This project has been highly interdisciplinary, located at the interface of physics, materials science, biophotonics and neuroscience, and successfully established OLEDs as new light source in different environments for optogenetics. This gives neuroscientists a new tool to better understand the brain and allows a more in depth research of neurological diseases.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

A large part of the project was aimed at the development of patterned, high-brightness blue OLEDs. Importantly, brightness levels exceeding 1 mW/mm2 were reached, which is a benchmark for light sources applied in optogenetics. In order to allow future flexible devices and to achieve a good spatial resolution, further research was pursued on improving thin-film encapsulation using atomic layer deposited oxides to protect the organic layers from the aqueous environment of cells.
The developed OLEDs were used to stimulate cultured neurons, and the electrical activity of the cells was monitored optically with fluorescent indicators. A quick response of the neurons to OLED light was observed, demonstrating that OLEDs can achieve the required brightness levels for optogenetics.
Furthermore, structured OLEDs were also applied in vivo to stimulate neuronal networks in Drosophila (fruit fly) larvae. Using light-sensitive proteins, sensory neurons in individual segments of the larvae were both activated and silenced.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

The NeurOLED project demonstrated for the first time that OLEDs can be used to stimulate neurons both in culture and in vivo. For the latter, a structured light source was developed that allowed targeting individual segments of fruit fly larvae and to quickly switch between targeted areas. Through behavioural observations of the larvae, new insight was gained into the neuronal networks underlying Drosophila locomotion (movement). The project is a major milestone on the way towards flexible high-density OLED arrays for precisely controlling large neuronal networks, which ultimately may enable new therapeutic techniques to alleviate neurological diseases such as epilepsy or Parkinson’s disease, or to restore vision in blind people.

Structured high-brightness OLEDs used for optogenetic stimulation of fruit fly larvae.